Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease

NCT01117818 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

335

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

BIOLOGICAL: active: AFFITOPE AD02
BIOLOGICAL: control: Placebo

Sponsor

Affiris AG